相关实验视频

Updated: Jun 15, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

放射性治疗阻断性在患有差异化甲状腺癌的患者中的预测因素

Majdouline Bel Lakhdar¹, Ayat Mouaden¹, Mourad Zekri¹

¹Department of Nuclear Medicine, Academic Hospital Ibn Sina, Faculty of Medicine and Pharmacy, University Mohammed V, Souissi, Rabat, Morocco.

World journal of nuclear medicine

|August 22, 2024

概括

差异化甲状腺癌 (DTC) 中放射性 (RAI) 折射率的预测因素包括年龄,瘤大小和转移. 瘤细胞癌亚型也增加了折射性风险.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
核医学是一种核医学.

背景情况:

分化甲状腺癌 (DTC) 是最常见的内分泌恶性瘤.
放射性 (RAI) 治疗是一种标准的治疗方法,但有一小部分患者会发展RAI折射性,影响生存.
确定RAI折射率的预测因素对于患者管理至关重要.

研究的目的:

为了确定差异化甲状腺癌中放射性折射性的独立预测因素.
帮助DTC患者早期风险分层和个性化治疗策略.

主要方法:

对90名差异化甲状腺癌患者的回顾性分析.
患者被分为RAI耐火 (RAIR) 和非RAIR组.
单变量和多变量逻辑回归用于识别预测因素.

主要成果:

雷尔-DTC的独立预测因素:诊断时的年龄≥54岁,原发性瘤直径≥29毫米,远端/节点转移.
瘤细胞癌组织学亚型显著增加了RAI折射性风险.
这些发现与之前的研究一致,强调早期检测和风险分层.

结论:

年龄,瘤大小,转移和组织学亚型是DTC中RAI折射性的关键预测因素.
早期识别高风险患者可以及时进行干预和个性化治疗.
需要进一步的前性研究来验证发现并探索分子标记物.

关键词:

RAI的折射性 (RAIR) 是指:分化甲状腺癌 (DTC)预测因素预测因素放射性疗法 (RAI) 是一种放射性疗法.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

相关概念视频

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...